Skip to Content

Tag: Stelara


John Rademacher

Specialty Providers

Option Care fueled by balanced portfolio, strong margins, strategic expansion

August 1, 2025Theresa Flaherty

BANNOCKBURN, Ill. – Option Care Health delivered a strong second quarter, reporting 15.4% revenue growth to $1.416 billion, with both its acute and chronic care portfolios showing mid-teen gains.  “The acute therapy growth we delivered in the quarter was notably higher than we believe the overall market to be growing,” said CFO Mike Shapiro on a recent call to discuss the company’s earnings. “(In the) acute portfolio, the product margins are north of 50%. The...

Home Infusion Therapy, John Rademacher, Option Care Health, Stelara


Read Full Articlered right arrow icon